Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALGB 19802: Intensified Chemotherapy for Adult ALL
NCT00003700Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 1999
- Primary completion
- Feb 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of daunorubicin, cytarabine, methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Cancer and Leukemia Group B. Started Jan 1999; status: completed.
02
Drugs
daunorubicincytarabinemethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00003700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003700.